with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa; pseudomembranous colitis associated with growth of Clostridium difficile and isolation of toxin (c. difficile toxin assay, Becton Dickinson, Cockeysville, Maryland); and evidence of systemic sepsis due to P. aeruginosa and Escherichia coli bacteraemia. Her therapy included gentamicin, pipericillin, oral and intravenous metronidazole and parenteral nutrition; therapeutic heparinization was commenced on the day after admission following the development of arterial emboli in her left and right arms; and mechanical ventilation was commenced subsequently when her condition deteriorated. Subsequent periodic bowel haemorrhage at each attempt to introduce enteral feeding negated these attempts. These bleeds reduced the haemoglobin (Hb) to 90 gll. Uneventful transfusions of packed cells were performed on days 48, 49, 50 and 52 (a total of six units). Despite these transfusions from a Hb of 90 g/J, there was a confirmed fall in Hb to a nadir of 83 g/l on day 62.
At this time when the patient was scheduled for debridement of her sternal wound and cover with a pectoralis major flap, her blood film was noted to show significant spherocytosis. Small numbers of spherocytes had been first observed seven days after the last transfusion (10 days previously). The patient had an unexplained falling Hb, a normal reticulocyte count of 95 X 10 9 /1, and a mildly elevated total bilirubin of 44 J.tmolll (normal range 0-18 J.tmolll) and a lactate dehydrogenase of 293 UII (normal range 100-200 U/I). Antibody screening and direct Coombs' test were repeatedly negative: drug-induced immune haemolysis, which is rare, was not tested for specifically, but was considered unlikely (although penicillins are documented to cause haemolysis this is restricted to benzylpenicillin which was not used in this case)'. Hereditary disease was ruled out by the appearance of spherocytes during the course of her illness: the absence of fragmented cells excluded membrane damage Anaesthesia and Intensive Care, Vol. 23, No. 2, April, 1995 associated with microangiopathy. Because of the clostridial colitis, the possibility of exposure of T cryptantigens due to bacterial enzymes was considered. Serologic screening with a lectin panel (Gamma Biologicals, Inc., Houston, Texas) gave a positive result with Arachis hypogea but negative reactions with Glycine soja, Salvia sclarea and Salvia hominum indicating a form of T activation. Further serological and biochemical studies* supported the involvement of the Th or Tx receptor rather than Tk. Her red blood cells (RBC) were polyagglutinable when tested with normal adult sera. Because of her critical clinical status, and the high risk of major bleeding at surgery as she was still heparinized, and to avoid exacerbation of haemolysis, washed RBC (of which four units were infused) were provided on a daily basis for intraoperative and early postoperative care; subsequently a further six units of washed RBC were infused without adverse effects. Low anti-T titre fresh frozen plasma was made available but was not used. The patient continued to deteriorate due to vegetations on her mitral, tricuspid and aortic valves and she died on day 88. Spherocytosis, a negative direct Coombs' test and positive test for T cryptantigen exposure persisted throughout her hospital stay.
DISCUSSION
The development of Coombs' negative spherocytosis in this patient who had confirmed sepsis and colitis associated with clostridial species prompted serological investigations which led to recognition of a form of T cryptantigen exposure and polyagglutinability. These findings complicated the management of this patient's complex medical and surgical problems. She had a continuing risk of life-threatening bleeding (aggravated because of heparinization), and a high likelihood of prolonged polyagglutinability due to the difficulty in eradicating the clostridial species from her colon. In view of her critical clinical condition and to avoid potential exacerbation of haemolysis, we opted for a cautious transfusion approach. She was transfused uneventfully on several occasions with washed RBC. Low anti-T titre fresh frozen plasma was procured but not required.
The T, Tn, Th, Tk, and Tx RBCcryptantigens are normally hidden on the membrane by a layer of neuraminic (sialic) acid, but may be exposed or "activated" by both non-microbial (Tn and Th) 6,7,9,1O or microbial (T, Th, Tk, or TX)5,6,1l-13 mechanisms. This may render the cells polyagglutinable (i.e., agglutinable by most adult sera) amd patients may suffer intravascular haemolysis due to either naturally occur- ring IgM anti-T, which is present in the plasma of most individuals after the age of 6 months 6 ,7,9,1l, or the infusion of plasma products 13 ,14. Non-microbial activation which is likely to involve a somatic mutation is usually persistent, is rare, and has been associated with myelodysplasia, acute myeloid leukemia 6 ,7,9 and congenital hypoplastic anaemias lO • Microbial activation involves membrane modification by enzymes which are released by some bacteria, protozoa, and viruses; it is a transient state which is increasingly being recognized. T and Th activation are due to neuraminidase activity and are most frequently associated with anaerobic organisms such as clostridial species or Bacteroides Jragiliso, 7.11,14,15 . Tk activation is due to (3 endo-or exogalactosidase and is frequently associated with aerobic organisms, although B. Jragilis has also been implicated 6 ,7,9,1l . Tx exposure most likely involves a neuraminidase l2 . In this patient it is most likely that neuraminidase released by the C difJicile organisms in her colon led to chemical membrane changes of the RBC and exposure of the T cryptantigens. Constitutively, there is minimal circulating enzyme activity from colonic organisms as it is localized by serum inhibitors ll • However, persistent clostridial infections may increase enzyme activity by overwhelming the capacity of local inhibitors. Spherocytosis was most likely the result of in vivo polyagglutinability due to naturally occurring IgM anti-T reacting with the exposed T cryptantigens. It is unlikely to be due to infused plasma, as spherocytosis first appeared seven days after an uneventful transfusion. A negative Coombs' test is usual with these phenomena unless the Coombs' reagent contains anti-T 16 or the patient has an extremely high titre of anti-T antibodyl5.
Although previously considered uncommon, recent studies indicate that cryptantigen exposure (as opposed to polyagglutinability) occurs in 0.5% of unselected hospitalized patients 17 and in 6 to 7.61110 of selected patients with sepsis, direct Coombs' test negative anaemia l8 , malignancyl8,19 or acquired immune deficiency syndrome (AIDS) or AIDS-related complex 20 . The frequency is highest (range 11-341110) in neonatal necrotizing enterocolitis 21 -23 . Other high risk groups include infants with bowel disorders or intraabdominal infectionsll,15 and infants with Streptococcus pneumoniae infections who may develop severe haemolytic uraemic syndrome 24 .
An approach to assist in early identification of patients who exhibit these phenomena and a guide to transfusion therapy is shown in Figure I , The presence of spherocytes or unexplained haemolysis in an appropriate clinical setting should arouse suspicion, In adult patients in intensive care this is most likely to be encountered in those with intra-abdominal surgical sepsis or bowel disorders especially those associated with clostridial infections. The development of severe haemolysis and renal failure following infusion of plasma-containing blood products may also alert to these phenomena; modification of transfusion therapy may allow recovery from these problemsl. Laboratory staff may first suspect these phenomena by irregularities in the blood grouping, such as discrepancies in forward and reverse groupings or inconsistencies in groups from one occasion to another 6 . 1l . With polyclonal reagents this occurs when there is spontaneous in vitro polyagglutination. This was not seen in this patient because monoclonal reagents were used. Standard cross-matching techniques usually do not detect these phenomena, although the minor crossmatch may be useful in some cases 2l . A simple and rapid screening test using the peanut lectin A. hypogea and the lectin G. soja should detect all forms of T cryptantigen exposure, although repeated testing may be necessary in some cases6.21-23. Epitope identification, which may give a clue as to whether the causative organism is anaerobic or aerobic, requires more extensive testing.
Due to the infrequency of these phenomena in adults, there is a lack of consensus regarding management of transfusion therapy. However, there are clear guidelines for neonates with necrotizing enterocolitis 21 because of frequent reports of severe haemolysis and occasional deaths in this group following infusion of plasma-containing blood productsll.21.23. It is generally recommended that washed RBCs should be employed and that low anti-T titre plasma products should be used with caution if plasma infusion is unavoidable. Washed RBCs take some hours to prepare and have a limited life span of only 12 hours. Low anti-T titre fresh frozen plasma is not usually a standard blood product available at Transfusion Centres. We screened a large panel of donors to identify those with low anti-T titre and thus provide a continuing source of this product and a potential source of low anti-T titre platelets. This has proved valuable for similar emergencies in other adults, infants and neonates with these problems2l. At the time this patient presented, the anti-T status of other plasma blood products was unknown. We have subsequently screened several batches of human serum albumin and intravenous gamma globulin (INTRAGAM), all kindly provided by Commonwealth Serum Laboratories, Melbourne, Victoria, and found them to be lacking in anti-T activity. Similar blood products from other manufacturers would require screening before use. Cryptantigen exposure and polyagglutinability should be excluded in patients with unexplained haemolysis and documented disease associations. It is prudent to develop policies to allow rapid screening for these problems and to ensure access to the range of blood products for the transfusion emergencies that may arise in such cases.
